A prospective registry evaluating angiographic and clinical outcomes after treatment with directional coronary atherectomy in patients with ischemic heart disease

A prospective registry evaluating angiographic and clinical outcomes after treatment with directional coronary atherectomy in patients with ischemic heart disease - DCA registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028615

Enrollment

150

Registered

2017-08-10

Start date

2017-06-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with ischemic heart disease undergoing percutaneous coronary intervention with directional coronary atherectomy 2) Patients who have provided written informed consent

Exclusion criteria

Exclusion criteria: 1) Patients who are intolerant to antiplatelet drugs 2) Patients who are intolerant to anticoagulant drugs 3) Patients who are considered inappropriate by the physicians

Design outcomes

Primary

Measure	Time frame
Angiographic restenosis at 12 months	—

Secondary

Measure	Time frame
All-cause death, cardiac death, myocardial infarction, target vessel revascularization, target lesion revascularization after procedure, at 6 months, 1 year, 2 years, 3 years, 4 years, and 5 years. Success rate of percutaneous coronary intervention. Periprocedural complications including bleeding, coronary perforation, rupture, dissection, spasm, acute occlusion, and shock. Changes in angiographic findings. Changes in lumen area, plaque burden, total atheroma volume, and percent atheroma volume by intravascular ultrasound. Bleeding during follow-up by the BARC bleeding definition, TIMI bleeding criteria, or GUSTO bleeding criteria.	—

Measure

Time frame

All-cause death, cardiac death, myocardial infarction, target vessel revascularization, target lesion revascularization after procedure, at 6 months, 1 year, 2 years, 3 years, 4 years, and 5 years. Success rate of percutaneous coronary intervention. Periprocedural complications including bleeding, coronary perforation, rupture, dissection, spasm, acute occlusion, and shock. Changes in angiographic findings. Changes in lumen area, plaque burden, total atheroma volume, and percent atheroma volume by intravascular ultrasound. Bleeding during follow-up by the BARC bleeding definition, TIMI bleeding criteria, or GUSTO bleeding criteria.

—

Countries

Japan

Contacts

Public ContactHiroshi Ueda

Koseikai Takai Hospital Cardiovascular Medicine

h-ueda@takai-hp.com0743655552

Outcome results